753 related articles for article (PubMed ID: 28695374)
1. Impact of aromaticity on anticancer activity of polypyridyl ruthenium(II) complexes: synthesis, structure, DNA/protein binding, lipophilicity and anticancer activity.
Čanović P; Simović AR; Radisavljević S; Bratsos I; Demitri N; Mitrović M; Zelen I; Bugarčić ŽD
J Biol Inorg Chem; 2017 Oct; 22(7):1007-1028. PubMed ID: 28695374
[TBL] [Abstract][Full Text] [Related]
2. New water-soluble ruthenium(II) terpyridine complexes for anticancer activity: synthesis, characterization, activation kinetics, and interaction with guanine derivatives.
Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
Inorg Chem; 2014 Jun; 53(12):6113-26. PubMed ID: 24884156
[TBL] [Abstract][Full Text] [Related]
3. New 4'-(4-chlorophenyl)-2,2':6',2″-terpyridine ruthenium(II) complexes: Synthesis, characterization, interaction with DNA/BSA and cytotoxicity studies.
Milutinović MM; Rilak A; Bratsos I; Klisurić O; Vraneš M; Gligorijević N; Radulović S; Bugarčić ŽD
J Inorg Biochem; 2017 Apr; 169():1-12. PubMed ID: 28088012
[TBL] [Abstract][Full Text] [Related]
4. Kinetic and mechanistic study on the reactions of ruthenium(ii) chlorophenyl terpyridine complexes with nucleobases, oligonucleotides and DNA.
Milutinović MM; Elmroth SK; Davidović G; Rilak A; Klisurić OR; Bratsos I; Bugarčić ŽD
Dalton Trans; 2017 Feb; 46(7):2360-2369. PubMed ID: 28139789
[TBL] [Abstract][Full Text] [Related]
5. DNA binding properties, histidine interaction and cytotoxicity studies of water soluble ruthenium(ii) terpyridine complexes.
Lazić D; Arsenijević A; Puchta R; Bugarčić ŽD; Rilak A
Dalton Trans; 2016 Mar; 45(11):4633-46. PubMed ID: 26855406
[TBL] [Abstract][Full Text] [Related]
6. Factors that influence the antiproliferative activity of half sandwich Ru(II)-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives.
Rilak A; Bratsos I; Zangrando E; Kljun J; Turel I; Bugarčić ŽD; Alessio E
Dalton Trans; 2012 Oct; 41(38):11608-18. PubMed ID: 22903512
[TBL] [Abstract][Full Text] [Related]
7. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
8. Kinetically labile ruthenium(II) complexes of terpyridines and saccharin: effect of substituents on photoactivity, solvation kinetics, and photocytotoxicity.
Kumar P; Singh P; Saren S; Pakira S; Sivakumar S; Patra AK
Dalton Trans; 2021 Jun; 50(23):8196-8217. PubMed ID: 34031678
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of Ru(II) piano-stool complexes with chloroquine and chelating ligands against breast and lung tumor cells: Interactions with DNA and BSA.
Colina-Vegas L; Villarreal W; Navarro M; de Oliveira CR; Graminha AE; Maia PIDS; Deflon VM; Ferreira AG; Cominetti MR; Batista AA
J Inorg Biochem; 2015 Dec; 153():150-161. PubMed ID: 26277415
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
11. Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.
Chen H; Parkinson JA; Parsons S; Coxall RA; Gould RO; Sadler PJ
J Am Chem Soc; 2002 Mar; 124(12):3064-82. PubMed ID: 11902898
[TBL] [Abstract][Full Text] [Related]
12. New ruthenium(II) complexes with quinone diimine and substituted bipyridine as inert ligands: synthesis, characterization, mechanism of action, DNA/HSA binding affinity and cytotoxic activity.
Međedović M; Rilak Simović A; Ćoćić D; Senft L; Matić S; Todorović D; Popović S; Baskić D; Petrović B
Dalton Trans; 2023 Jan; 52(5):1323-1344. PubMed ID: 36629870
[TBL] [Abstract][Full Text] [Related]
13. Ru
Lenis-Rojas OA; Robalo MP; Tomaz AI; Carvalho A; Fernandes AR; Marques F; Folgueira M; Yáñez J; Vázquez-García D; López Torres M; Fernández A; Fernández JJ
Inorg Chem; 2018 Nov; 57(21):13150-13166. PubMed ID: 30339386
[TBL] [Abstract][Full Text] [Related]
14. Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo.
Savic M; Arsenijevic A; Milovanovic J; Stojanovic B; Stankovic V; Rilak Simovic A; Lazic D; Arsenijevic N; Milovanovic M
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066568
[TBL] [Abstract][Full Text] [Related]
15. A new bis-pyrazolylpyridine ruthenium(III) complex as a potential anticancer drug:
Lazić D; Scheurer A; Ćoćić D; Milovanović J; Arsenijević A; Stojanović B; Arsenijević N; Milovanović M; Rilak Simović A
Dalton Trans; 2021 Jun; 50(22):7686-7704. PubMed ID: 33982702
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, structural characterization, in vitro DNA binding, and antitumor activity properties of Ru(II) compounds containing 2(2,6-dimethoxypyridine-3-yl)-1H-imidazo(4,5-f)[1, 10]phenanthroline.
Chintakuntla N; Putta VR; Mallepally RR; K N; Vuradi RK; Kotha LR; Singh SS; Sirasani S
Nucleosides Nucleotides Nucleic Acids; 2020; 39(5):760-791. PubMed ID: 31983278
[TBL] [Abstract][Full Text] [Related]
17. Photocytotoxic kinetically stable ruthenium(II)-
Sayala J; Srivastava E; Kumar P; Shukla N; Kumar A; Patra AK
Dalton Trans; 2024 Mar; 53(10):4580-4597. PubMed ID: 38349214
[TBL] [Abstract][Full Text] [Related]
18. CF3 Derivatives of the Anticancer Ru(III) Complexes KP1019, NKP-1339, and Their Imidazole and Pyridine Analogues Show Enhanced Lipophilicity, Albumin Interactions, and Cytotoxicity.
Chang SW; Lewis AR; Prosser KE; Thompson JR; Gladkikh M; Bally MB; Warren JJ; Walsby CJ
Inorg Chem; 2016 May; 55(10):4850-63. PubMed ID: 27143338
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic Ruthenium(II) Complexes Containing a Dangling Pyridine: Selectivity for Diseased Cells Mediated by pH-Dependent DNA Binding.
Sangeetha S; Murali M
Inorg Chem; 2022 Feb; 61(6):2864-2882. PubMed ID: 35099196
[TBL] [Abstract][Full Text] [Related]
20. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.
Anjomshoa M; Torkzadeh-Mahani M
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]